Skip to content
Participate in our active studiesSubscribe to our Mailing List
AB Science
Masitinib and AB8939 – Two compounds with breakthrough mechanism of action
AB Science AB Science
  • Home
  • Company
    • Corporate Overview
    • Executive Commitee
    • Scientific Committee
    • Values
  • Science
    • Overview
    • Masitinib in neurodegenerative disorders
    • Masitinib in inflammatory diseases
    • Masitinib in oncology
    • Masitinib in viral diseases
    • AB8939 in oncology
    • Publications
  • Pipeline
    • Pipeline Overview
    • Masitinib
      • Multiple Sclerosis
      • Amyotrophic Lateral Sclerosis
      • Alzheimer’s Disease
      • Indolent Systemic Mastocytosis
      • Mast Cell Activation Syndrome
      • Severe Asthma
      • Prostate Cancer
      • Pancreatic Cancer
      • COVID-19
    • AB8939
  • News and Media
    • Press releases
    • In the Media
    • Webconference replay
  • Investors
    • Why invest in AB Science
    • Investor Kit
    • Regulated information
      • Annual reports
      • Half-year reports
      • Social and environmental responsabilities
      • Shareholders General Meeting
      • Outstanding shares and voting rights
      • Regulated agreements
    • Stock Information
      • General Information
      • Analyst Coverage
    • Financial Calendar
    • Events
  • Masivet®
    • About Masivet®
    • Medical information and Pharmacovigilance
  • Careers
  • Contact
  • English
  • French
Search:
  • Home
  • Company
    • Corporate Overview
    • Executive Commitee
    • Scientific Committee
    • Values
  • Science
    • Overview
    • Masitinib in neurodegenerative disorders
    • Masitinib in inflammatory diseases
    • Masitinib in oncology
    • Masitinib in viral diseases
    • AB8939 in oncology
    • Publications
  • Pipeline
    • Pipeline Overview
    • Masitinib
      • Multiple Sclerosis
      • Amyotrophic Lateral Sclerosis
      • Alzheimer’s Disease
      • Indolent Systemic Mastocytosis
      • Mast Cell Activation Syndrome
      • Severe Asthma
      • Prostate Cancer
      • Pancreatic Cancer
      • COVID-19
    • AB8939
  • News and Media
    • Press releases
    • In the Media
    • Webconference replay
  • Investors
    • Why invest in AB Science
    • Investor Kit
    • Regulated information
      • Annual reports
      • Half-year reports
      • Social and environmental responsabilities
      • Shareholders General Meeting
      • Outstanding shares and voting rights
      • Regulated agreements
    • Stock Information
      • General Information
      • Analyst Coverage
    • Financial Calendar
    • Events
  • Masivet®
    • About Masivet®
    • Medical information and Pharmacovigilance
  • Careers
  • Contact

Monthly Archives: June 2019

You are here:
  1. Home
  2. 2019
  3. June

Results of interim analysis for masitinib in Alzheimer’s Disease

2019By Alexis BERNARDJune 26, 2019

26/06/2019 – AB Science reports the outcome from the interim analysis of study AB09004 in Alzheimer’s Disease

June 14 2019 web conference presentation

2019By Alexis BERNARDJune 14, 2019

14/06/2019 – AB Science web conference presentation

Positive IDMC recommendation following interim analysis in pancreatic cancer

2019By Alexis BERNARDJune 12, 2019

12/06/2019 – AB Science announces the positive recommendation of IDMC following the interim analysis of AB12005 study in the first-line treatment of pancreatic cancer

Upcoming news flow

2019By Alexis BERNARDJune 10, 2019

10/06/2019 – AB Science is providing the upcoming news flow of the Company

Updated corporate overview

2019By Alexis BERNARDJune 10, 2019

10/06/2019 – AB Science is providing an updated coporate overview of the Company

Summary of the webconference held on June 5, 2019

2019By Alexis BERNARDJune 5, 2019

05/06/2019 – AB Science is providing a summary of the web conference held on 5 June, 2019

June 5 2019 web conference presentation

2019By Alexis BERNARDJune 5, 2019

05/06/2019 – AB Science web conference – Part 2

Summary of the webconference held on June 4, 2019

2019By Alexis BERNARDJune 4, 2019

04/06/2019 – AB Science is providing a summary of the web conference held on 4 June, 2019

June 4 2019 web conference presentation

2019By Alexis BERNARDJune 4, 2019

04/06/2019 – AB Science web conference presentation (Part 1)

AB Science
© AB Science – All right reserved
Go to Top